Approaches to Myeloproliferative Neoplasms

home / insights / approaches-to-myeloproliferative-neoplasms

Expert panelists review current and emerging treatment approaches in myeloproliferative neoplasms, with focused discussion on monitoring, sequencing, and combination therapy strategies using JAK inhibitors in myelofibrosis.

Aaron Gerds, MD, an expert on myeloproliferative neoplasms

EP. 1: Overview of MPNs

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
March 22nd 2023

A brief overview of myeloproliferative neoplasms and the associated signs and symptoms commonly presenting in patients.

Aaron Gerds, MD, an expert on myeloproliferative neoplasms

EP. 2: Systemic Treatment Options for Polycythemia Vera

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
March 22nd 2023

A review of systemic treatment options used in polycythemia vera and the roles these play in the current treatment landscape.

Pankit Vachhani, MD, an expert on myeloproliferative neoplasms

EP. 3: Polycythemia Vera: Prognosis and Risk for Progression to Myelofibrosis

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
March 29th 2023

Panel experts share insight regarding prognosis for patients with polycythemia vera and the associated risk for progression to myelofibrosis.

Naveen Pemmaraju, MD, an expert on myeloproliferative neoplasms

EP. 4: Myelofibrosis: Classification, Risk Factors, and Biomarkers

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
March 29th 2023

Shared insight on classification, risk factors, and important biomarkers and pathways in myelofibrosis.

Naveen Pemmaraju, MD, an expert on myeloproliferative neoplasms

EP. 5: Myelofibrosis: Diagnosis and Prognostic Risk Assessment

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
April 5th 2023

Comprehensive discussion highlighting diagnostic and molecular testing involved in the diagnosis of myelofibrosis, challenges related to early diagnosis, and consideration factors for assessing prognostic risk.

Pankit Vachhani, MD, an expert on myeloproliferative neoplasms

EP. 6: Transplant Therapy in Myelofibrosis

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
April 5th 2023

Expert perspectives on how to identify and assess patients with myelofibrosis for transplant therapy.

Aaron Gerds, MD, an expert on myeloproliferative neoplasms

EP. 7: JAK Inhibitors in Myelofibrosis

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
April 12th 2023

Panel experts briefly review supporting data for the use of JAK inhibitors in myelofibrosis and discuss the impact of emerging data on the current treatment landscape.

Naveen Pemmaraju, MD, an expert on myeloproliferative neoplasms

EP. 8: Monitoring Strategies in Myelofibrosis

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
April 12th 2023

Shared insights on monitoring strategies for myelofibrosis, including important considerations for patients receiving treatment with JAK inhibitors.

Pankit Vachhani, MD, an expert on myeloproliferative neoplasms

EP. 9: Treatment Sequencing Approaches for Myelofibrosis

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
April 19th 2023

Expert perspectives on treatment sequencing strategies with JAK inhibitors for myelofibrosis.

Pankit Vachhani, MD, an expert on myeloproliferative neoplasms

EP. 10: Novel Therapies Under Investigation for Myelofibrosis

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
April 19th 2023

Focused discussion on emerging trial data surrounding novel, investigational therapies for myelofibrosis.

Naveen Pemmaraju, MD, an expert on myeloproliferative neoplasms

EP. 11: Potential Combination Therapy Approaches with Ruxolitinib in Myelofibrosis

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
April 26th 2023

A review of recent trial data evaluating combination therapy approaches with ruxolitinib in myelofibrosis, including the rationale and potential clinical benefits associated with the use of these emerging strategies.

Pankit Vachhani, MD, an expert on myeloproliferative neoplasms

EP. 12: Looking Ahead in Treating Myeloproliferative Neoplasms

Aaron Gerds, MD;Pankit Vachhani, MD;Naveen Pemmaraju, MD
April 26th 2023

Shared closing thoughts on the future treatment landscape for myeloproliferative neoplasms, including future and emerging areas of research and remaining areas of unmet need.